Clinical Trial Update: Study to Evaluate the Therapeutic Equivalence and Safety of Fluticasone Furoate and Vilanterol Inhalation Powder 100 mcg/25 mcg and BREO ELLIPTA 100 mcg/25 mcg in Participants With Asthma [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating therapeutic equivalence and safety of generic fluticasone furoate/vilanterol inhalation powder vs BREO ELLIPTA in asthma; not yet recru…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• BREO ELLIPTA 100 mcg/25 mcg (fluticasone furoate/vilanterol)
• Fluticasone furoate/vilanterol inhalation powder (generic) 100 mcg/25 mcg (fluticasone furoate/vilanterol)

Snippet

Sponsor: Sandoz | Conditions: Respiratory | Phase 3 | Status: NOT_YET_RECRUITING